Great Point Partners as of Dec. 31, 2022
Portfolio Holdings for Great Point Partners
Great Point Partners holds 42 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 7.5 | $38M | 800k | 47.95 | |
| Xenon Pharmaceuticals (XENE) | 6.6 | $34M | 850k | 39.43 | |
| Rapt Therapeutics (RAPT) | 5.6 | $28M | 1.4M | 19.80 | |
| Alpine Immune Sciences (ALPN) | 5.2 | $27M | 3.6M | 7.35 | |
| Pliant Therapeutics (PLRX) | 5.0 | $26M | 1.3M | 19.33 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.0 | $26M | 160k | 159.31 | |
| Seagen | 4.0 | $21M | 161k | 128.51 | |
| Point Biopharma Global | 3.6 | $19M | 2.5M | 7.29 | |
| Novocure Ord Shs Put Option (NVCR) | 3.5 | $18M | 241k | 73.35 | |
| Iveric Bio | 3.5 | $18M | 825k | 21.41 | |
| Aclaris Therapeutics (ACRS) | 3.1 | $16M | 1.0M | 15.75 | |
| Heron Therapeutics (HRTX) | 3.1 | $16M | 6.4M | 2.50 | |
| Ultragenyx Pharmaceutical (RARE) | 3.1 | $16M | 342k | 46.33 | |
| Optinose (OPTN) | 2.9 | $15M | 7.9M | 1.85 | |
| Ventyx Biosciences (VTYX) | 2.6 | $13M | 401k | 32.79 | |
| Cincor Pharma | 2.5 | $13M | 1.0M | 12.29 | |
| Viking Therapeutics (VKTX) | 2.4 | $12M | 1.3M | 9.40 | |
| Day One Biopharmaceuticals I (DAWN) | 2.3 | $12M | 545k | 21.52 | |
| Ptc Therapeutics I (PTCT) | 2.3 | $12M | 302k | 38.17 | |
| Aerovate Therapeutics (AVTE) | 2.2 | $11M | 379k | 29.30 | |
| Travere Therapeutics (TVTX) | 2.0 | $10M | 475k | 21.03 | |
| Cymabay Therapeutics | 1.9 | $9.7M | 1.6M | 6.27 | |
| Sarepta Therapeutics (SRPT) | 1.9 | $9.5M | 73k | 129.58 | |
| Rocket Pharmaceuticals Call Option (RCKT) | 1.7 | $8.8M | 451k | 19.57 | |
| Kalvista Pharmaceuticals (KALV) | 1.4 | $7.1M | 1.1M | 6.76 | |
| Amylyx Pharmaceuticals (AMLX) | 1.4 | $7.0M | 190k | 36.95 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.3 | $6.7M | 643k | 10.50 | |
| Erasca (ERAS) | 1.3 | $6.6M | 1.5M | 4.31 | |
| Intercept Pharmaceuticals In | 1.3 | $6.5M | 529k | 12.37 | |
| Acumen Pharmaceuticals (ABOS) | 1.2 | $6.0M | 1.1M | 5.40 | |
| Mirati Therapeutics | 1.2 | $6.0M | 133k | 45.31 | |
| Verve Therapeutics (VERV) | 1.1 | $5.8M | 300k | 19.35 | |
| Albireo Pharma | 1.1 | $5.8M | 267k | 21.61 | |
| Larimar Therapeutics (LRMR) | 1.0 | $5.3M | 1.3M | 4.13 | |
| Urogen Pharma (URGN) | 1.0 | $5.0M | 560k | 8.87 | |
| Precision Biosciences Ord | 0.9 | $4.5M | 3.8M | 1.19 | |
| Gracell Biotechnologies Sponsored Ads | 0.9 | $4.5M | 2.0M | 2.30 | |
| Generation Bio (GBIO) | 0.8 | $4.0M | 1.0M | 3.93 | |
| Evolus (EOLS) | 0.3 | $1.4M | 190k | 7.51 | |
| Alkermes SHS (ALKS) | 0.2 | $1.2M | 46k | 26.13 | |
| Immunic (IMUX) | 0.2 | $885k | 632k | 1.40 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $465k | 15k | 30.99 |
